January 28, 2014 — ReCor Medical advanced its Paradise System for renal denervation (RDN) for treatment resistant hypert ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
January 10, 2014 — CVRx Inc. announced findings from a health-economic analysis published in the Journal of Hypertension ...
January 10, 2014
January 9, 2014 — Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat ...
January 09, 2014
January 2, 2014 — Medtronic Inc. announced that the first patients were randomized in Symplicity HTN-4, which will ...
January 02, 2014
December 24, 2013 — Clinical trials for a promising new class of cholesterol-lowering medications, a long-awaited repair ...
December 24, 2013
December 6, 2013 — Medtronic Inc. announced CE mark in Europe and Therapeutic Goods Administration (TGA) listing in ...
December 06, 2013December 6, 2013 – Medtronic, Inc. presented three-year data from SYMPLICITY HTN-2, the first and longest-running ...
December 06, 2013
Feature | Dave Fornell
The use of renal stenting in combination with medication-based therapy to treat hypertension showed no improvement in ...
November 19, 2013November 13, 2013 — Petr Neuzil, M.D., Nemocnice Na Homolce Hospital, Prague, Czech Republic, presented three-month ...
November 13, 2013
November 13, 2013 — Medtronic Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an ...
November 13, 2013
November 8, 2013 — A new way of using blood pressure-lowering medications could prevent more than a fourth of heart ...
November 08, 2013
October 31, 2013 — Patients treated with the Boston Scientific Vessix Renal Denervation System experienced a significant ...
October 31, 2013October 28, 2013 — CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education ...
October 28, 2013
October 25, 2013 — Kona Medical Inc. announced it has closed a Series D equity financing of $10 million. Morningside ...
October 25, 2013
October 14, 2013 — Since its debut in 2010, the renal denervation market has generated enthusiasm across the medical ...
October 14, 2013